Breaking News on Global Pharmaceutical Technology & Manufacturing

Lilly buys Avid to boost diagnostics and AD biz

10-Nov-2010 - US drugmaker Eli Lilly said it will buy Avid Radiopharmaceuticals to expand its neuroscience diagnostics business.

AMRI posts loss, but forecasts 23% contract rev growth in Q4

10-Nov-2010 - API maker AMRI cited arbitration costs, efforts to address a US FDA warning letter and acquisitions as key factors in Q3 loss, but predicted that large-scale contract manufacturing business will...

News in brief

Endo's takeover of Penwest gets shareholder approval

08-Nov-2010 - Penwest Pharmaceuticals shareholders have voted in favour of Endo Pharmaceuticals takeover plan, paving the way for the $144m merger.

ATMI acquires Artelis in ‘disposables’ deal

04-Nov-2010 - ATMI has acquired Artelis, a Belgian biotech firm, in an effort to “get closer to customers” by widening its disposable technology portfolio to the life sciences research and manufacturing sector.

Hikma builds in US injectables sector with Baxter unit buy

02-Nov-2010 - Baxter International will sell its US generic injectables business to UK-based manufacturer Hikma Pharmaceuticals

News in brief

Genzyme values itself at $22.7bn, $20 per share higher than Sanofi bid

25-Oct-2010 - US Biotechnology firm Genzyme predicts 2011 earnings in $4.30 to $4.60 range, which would make it worth $89 per share or $22.7bn.

News in brief

US OKs Sanofi’s Genzyme bid; French strike hits Romainville plant

20-Oct-2010 - Sanofi Aventis has been given the go ahead to pursue US biotech Genzyme by the country’s antitrust authorities.

News in brief

WR Grace’s acquisition of Synthetech approved by US Bankruptcy Court

19-Oct-2010 - Industrial catalysis firm WR Grace has been OKed to acquire fine chemicals group Synthetech by the US Bankruptcy Court.

News in brief

Sanofi to cut 1,700 US jobs

11-Oct-2010 - Sanofi Aventis says eliminating 1,700 jobs in US will help it concentrate resources on business development, investment in late-stage development projects and will position it for growth after patent expiry.

Sanofi launches hostile Genzyme bid; Pfizer close on Uplyso Brazil deal

04-Oct-2010 - French drugmaker Sanofi Aventis has tabled an $18.5m, $69 per share, hostile takeover bid for Genzyme after failing to secure an amicable acquisition.

News in brief

Lupin hold majority stake in Generic Health

30-Sep-2010 - Lupin has notified the Bombay Stock Exchange (BSE) that is has acquired a majority stake in Australian pharmaceutical company, Generic Health.

DSM seeks Asian partners; welcomes J&J Crucell takeover

23-Sep-2010 - DSM aims to keep pace with the rapid evolution of pharmaceutical sector through increased partnering and a focus on Asia.

Solvay integration will cost manufacturing jobs, says Abbott

22-Sep-2010 - Abbott Laboratories says it will shed manufacturing jobs as part integration of the pharmaceutical business it bought from Solvay earlier this year.

Actavis looks to enter biosimilars through acquisition

08-Sep-2010 - Actavis is looking to enter the biosimilars sector through the proposed acquisition of a stake in Biopartners.

Genzyme rejects Sanofi’s $18.5bn bid; IPT looks at biotech’s turbulent 18-months

31-Aug-2010 - Genzyme has rejected Sanofi-Aventis' $18.5bn (€14.5bn) takeover bid, describing it as offering no improvement in price on the previous proposal and failing “to establish a basis for engagement.”

Changes to India’s pharma imports & exports, visualised

30-Aug-2010 - Proposed changes to compulsory licensing and foreign ownership oversight in India sparked discussion last week. To explore the topic, in-PharmaTechnologist presents interactive charts detailing market changes in the country over...

Lonza buys Vivante to expand custom biologics biz

30-Aug-2010 - Lonza buys viral-based biologics maker Vivante GMP Solutions to broaden custom manufacturing offering.

News in brief

Sanofi goes public on $18.5bn bid for “unwilling” Genzyme

30-Aug-2010 - Sanofi Aventis has gone public with its $18.5bn (€14.5bn) takeover bid for US biotech Genzyme, putting more pressure on firm’s “unwilling” board

Amcor: Alcan costs cut profits; but pharma flexibles unit boosts sales

26-Aug-2010 - The Flexibles packaging unit acquired in Alcan Packaging deal boost sales, but integration costs hit fiscal 2010 net profit at Australia’s Amcor.

India ponders compulsory licensing revisions to cut prices

25-Aug-2010 - India is considering strengthening compulsory licensing provisions, which allow third parties to produce patented products, in response to concerns about overseas takeovers and drug prices.

News in brief

Cipla to buy Meditab for $28m

25-Aug-2010 - Indian pharmaceutical firm Cipla is to buy Meditab Specialties to boost active pharmaceutical ingredient (API) and intermediate production capacity.

Imclone closes US Erbitux plant

18-Aug-2010 - Imclone has closed the manufacturing facility in Branchburg, New Jersey where it produces the cancer drug Erbitux, according to reports in the US media.

Merck to buy back Riverside plant for key API supply

11-Aug-2010 - US drugmaker Merck & Co has announced plans to reacquire a Pennsylvania manufacturing plant to guarantee supply of key active pharmaceutical ingredient (API).

Endo to buy Penwest for Opana ER tech

10-Aug-2010 - Endo Pharmaceuticals will pay $168m (€127.7m) for drug delivery tech and formulations firm Penwest Pharmaceuticals in bid to expand pain portfolio.

US patients call for Fabrazyme patent break; Are you watching Sanofi?

03-Aug-2010 - Calls for US government to break Genzyme’s Fabrazyme patents accompany more speculation that French drugmaker Sanofi Aventis is in takeover talks.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...